AIDS Clinical Trials Group Spotlights on Amita Gupta

Date: 02/19/2015

Publication:

ACTG Spotlight

The AIDS Clinical Trials Group (ACTG) Network recognizes researchers and staff actively doing great work.  Spotlight highlights Dr. Gupta’s work in TB research in India.

Meet Amita Gupta

As a child, Amita Gupta, MD, witnessed infectious diseases firsthand while visiting extended family in India.

“I spent summers in India and saw the effects of polio, hepatitis B, tuberculosis and malaria,” she says. “Then when I was in college, I was galvanized by the world of HIV activism. I found myself more and more interested in working on HIV, volunteering at AIDS Action and Fenway Health in Boston. I later worked on HIV/AIDS at the Massachusetts Health Department.”

Read the complete article.
 

Clinical Trials

A5320: Viral Hepatitis C Infection Long-term Cohort Study...

A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...

Read More

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

Read More

Identification of Biomarkers That Can Predict Progression...

Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...

Read More

Impact of Tuberculosis Infection on HIV-1 Antibody Response...

Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...

Read More

A5361s: Pitavastatin to REduce Physical Function Impairment...

A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...

Read More